<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Prelabor rupture of membranes before and at the limit of viability
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Prelabor rupture of membranes before and at the limit of viability
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Prelabor rupture of membranes before and at the limit of viability
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Thomas McElrath, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Charles J Lockwood, MD, MHCM
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vanessa A Barss, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 28, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prelabor rupture of the fetal membranes (PROM) before or at the limit of viability is associated with substantial serious pediatric morbidity and mortality. The limit of viability can be defined as the earliest stage of fetal maturity when there is a reasonable chance, although not a high likelihood, of extrauterine survival, and can be loosely considered to be &lt;23+0 weeks of gestation.
        </p>
        <p>
         The etiology, diagnosis, and complications of PROM at a previable gestational age will be reviewed here. The diagnosis and management of preterm and term PROM later are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6754.html" rel="external">
          "Preterm prelabor rupture of membranes: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/120959.html" rel="external">
          "Preterm prelabor rupture of membranes: Management and outcome"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6757.html" rel="external">
          "Prelabor rupture of membranes at term: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H546693126">
         <span class="h1">
          INCIDENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         PROM before or at the limit of viability complicates 0.1 to 0.7 percent of pregnancies [
         <a href="#rid1">
          1-3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CAUSES AND RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         PROM before or at the limit of viability may occur spontaneously or it may be related to an invasive procedure that breaches the fetal membranes.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Spontaneous
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis of spontaneous PROM before or at the limit of viability is not well understood. Multiple etiologies are probably involved and operate along various pathways involving both mechanical and nonmechanical factors. It is likely these pathways lead to a final common pathway that culminates in membrane rupture. (See
         <a class="medical medical_review" href="/z/d/html/6785.html" rel="external">
          "Spontaneous preterm birth: Pathogenesis"
         </a>
         .)
        </p>
        <p>
         Risk factors for PROM before or at the limit of viability are similar to those for preterm labor  (
         <a class="graphic graphic_table graphicRef68992" href="/z/d/graphic/68992.html" rel="external">
          table 1
         </a>
         ). The major risk factors appear to be a prior history of preterm labor, PROM before or at the limit of viability, cervical insufficiency, or a current pregnancy complicated by multiple gestation or antepartum bleeding. It is likely that both PROM before or at the limit of viability and preterm labor are expressions of a more general process of intrauterine inflammation and thus share many antecedents [
         <a href="#rid4">
          4
         </a>
         ]. Since the fetal membranes are avascular, they may be particularly vulnerable to the local effects of inflammatory reactions.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          After invasive procedures
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Amniocentesis
         </strong>
         – Diagnostic amniocentesis is the most common procedure associated with PROM before or at the limit of viability. PROM occurs in approximately 1 percent of these procedures [
         <a href="#rid5">
          5,6
         </a>
         ]. In contrast to spontaneous PROM before or at the limit of viability, leakage of amniotic fluid shortly after amniocentesis is typically associated with better outcomes, possibly because of "resealing" of the membranes after amniocentesis [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Resealing and reaccumulation of fluid'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5390.html" rel="external">
          "Diagnostic amniocentesis", section on 'Leakage of amniotic fluid'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fetoscopy, fetal surgery, and percutaneous umbilical vein blood sampling
         </strong>
         – These procedures are more likely to cause PROM before or at the limit of viability than amniocentesis. The risk is highest with fetal surgery and fetoscopy. In the latter case, clinical experience suggests that the risk is related to the number and diameter of ports and the duration of manipulation [
         <a href="#rid8">
          8
         </a>
         ]. Single port operative procedures are associated with a 6 to 10 percent incidence of membrane rupture; the risk is lower for diagnostic procedures, but much higher (20 to 30 percent [
         <a href="#rid9">
          9
         </a>
         ]) for operative procedures involving two or more ports and long operating times.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cerclage
         </strong>
         – Rupture of membranes can occur at or after physical examination-, ultrasound-, or history-indicated cerclage placement, and has a poor prognosis. However, cerclage placement is not necessarily causal as these patients have underlying risk factors for preterm birth [
         <a href="#rid10">
          10,11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6737.html" rel="external">
          "Transvaginal cervical cerclage", section on 'Removal of cerclage after PPROM'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6737.html" rel="external">
          "Transvaginal cervical cerclage", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLINICAL MANIFESTATIONS AND DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical manifestations and diagnosis of ruptured membranes are the same across gestation and are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6754.html" rel="external">
          "Preterm prelabor rupture of membranes: Clinical manifestations and diagnosis", section on 'Diagnostic evaluation and diagnosis'
         </a>
         .)
        </p>
        <p>
         The diagnosis of PROM before or at the limit of viability is based upon a characteristic history (leaking fluid from the vagina) and physical examination (visualization of fluid flowing from the endocervical canal and pooling in the vagina), supplemented by ultrasound examination and standard laboratory tests in cases of diagnostic uncertainty.
        </p>
        <p class="headingAnchor" id="H318389413">
         <span class="h1">
          COURSE
         </span>
        </p>
        <p class="headingAnchor" id="H940726278">
         <span class="h2">
          Resealing and reaccumulation of fluid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Up to 14 percent of pregnant people with spontaneous PROM before or at the limit of viability eventually stop leaking amniotic fluid, presumably due to resealing of the fetal membranes [
         <a href="#rid12">
          12-14
         </a>
         ]. Cessation of leakage is probably not due to actual repair and regeneration of the membranes, but rather to changes in the decidua and myometrium that block further leakage [
         <a href="#rid15">
          15
         </a>
         ]. This subgroup of pregnancies has outcomes comparable to pregnancies uncomplicated by amniorrhexis [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         A second subset of patients continue to leak fluid but have partial reaccumulation of amniotic fluid. Approximately 25 percent of patients with PROM before or at the limit of viability reaccumulate fluid on ultrasound examination during expectant management [
         <a href="#rid16">
          16,17
         </a>
         ].
        </p>
        <p>
         As noted above, patients with iatrogenic PROM before or at the limit of viability after amniocentesis usually reseal membranes within a week and have good pregnancy outcomes. The relatively discrete and focal nature of the iatrogenic membrane disruption when compared with the more ragged and larger defect that occurs with spontaneous membrane rupture likely contributes to these differences in resealing rates. (See
         <a class="medical medical_review" href="/z/d/html/5390.html" rel="external">
          "Diagnostic amniocentesis", section on 'Leakage of amniotic fluid'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2843497413">
         <span class="h2">
          Latency/preterm birth
         </span>
         <span class="headingEndMark">
          —
         </span>
         The time interval between membrane rupture and delivery is a critical factor in determining outcome in PROM before or at the limit of viability. In the author's review of studies in which the weighted mean gestational age at PROM was 23.5 weeks of gestation [
         <a href="#rid12">
          12,13,16-28
         </a>
         ], the weighted mean latency from gestational age at PROM before or at the limit of viability to delivery was 11 days, and the weighted median latency was 6.8 days.
        </p>
        <p>
         The large difference between mean and median latency is because the majority of pregnancies complicated by PROM before or at the limit of viability deliver soon after presentation; approximately 50 percent of patients remain pregnant beyond the first week after rupture. By 28 days post-rupture, 84 percent of pregnancies complicated by PROM before or at the limit of viability have delivered. However, for pregnancies not delivering within the first 24 hours, the mean latency is 10 to 14 days.
        </p>
        <p>
         Several authors have suggested that there is an inverse relationship between latency and gestational age at rupture: Ruptures occurring earlier in gestation appear to have longer latencies [
         <a href="#rid16">
          16,19,21,23-25,29
         </a>
         ]. This inverse relationship may represent "right censoring"; patients who deliver shortly after arriving on the labor floor are often excluded from latency studies and thus these studies may exclude patients more likely to be at an advanced gestational age.
        </p>
        <p>
         In addition, there appears to be a correlation between the amount of residual amniotic fluid and the latency period; severe oligohydramnios is associated with the shortest average latency [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          PREGNANCY COMPLICATIONS AND OUTCOMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pregnancy complications associated with PROM before or at the limit of viability include preterm birth, maternal and/or fetal/neonatal infection, placental abruption, umbilical cord prolapse, fetal/neonatal deformation, fetal or neonatal death, retained placenta, and need for cesarean birth via a classical hysterotomy incision.
        </p>
        <p>
         Counseling the patient with PROM before or at the limit of viability about pregnancy complications and pediatric outcome is challenging because of the small size, different gestational age ranges, and retrospective nature of the multiple studies on this subject. The majority of these reports refer to a single institutional experience, frequently prior to the widespread use of antepartum antibiotic prophylaxis, antepartum glucocorticoids to accelerate fetal lung maturation, and neonatal surfactant therapy. In addition, these studies often have differing inclusion/exclusion and diagnostic criteria and limited ability to adjust for confounders. Despite these limitations, the body of data provides remarkably consistent conclusions and estimates of the magnitude of risk with expectant management.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Chorioamnionitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chorioamnionitis complicates approximately 30 to 40 percent of PROM cases before or at the limit of viability [
         <a href="#rid17">
          17,21,22,24,31-33
         </a>
         ]. It is more common in pregnancies with PROM before or at the limit of viability than in pregnancies without PROM delivering at a similar gestational age [
         <a href="#rid13">
          13,25,34
         </a>
         ], or in pregnancies with PROM occurring later in gestation [
         <a href="#rid35">
          35,36
         </a>
         ].
        </p>
        <p>
         Chorioamnionitis can be a cause or a result of PROM before or at the limit of viability. It may cause PROM because infection of intact membranes weakens them, thereby facilitating rupture; it can be a sequelae of PROM because ruptured membranes are less effective as a barrier to transcervical migration of cervicovaginal flora. (See
         <a class="medical medical_review" href="/z/d/html/6785.html" rel="external">
          "Spontaneous preterm birth: Pathogenesis"
         </a>
         .)
        </p>
        <p>
         While subclinical chorioamnionitis may be present prior to membrane rupture, it typically becomes clinically apparent early in the latency period; more than one-half of cases occur within the first seven days after rupture [
         <a href="#rid12">
          12,18,19,22
         </a>
         ]. The maximum clinical occurrence is on the second through fifth day after rupture [
         <a href="#rid12">
          12,37
         </a>
         ]. After the first week of latency, the incidence of clinical chorioamnionitis falls dramatically [
         <a href="#rid12">
          12,19,21,22,38,39
         </a>
         ]. The higher frequency of clinical chorioamnionitis early in the latency period suggests that subclinical infection was likely present prior to membrane rupture and may have been the cause.
        </p>
        <p>
         Clinically evident chorioamnionitis is associated with onset of preterm labor and birth, thus it is a major cause of shortened latency. The risk of developing chorioamnionitis after PROM before or at the limit of viability is increased in patients with very low residual amniotic fluid volumes [
         <a href="#rid17">
          17
         </a>
         ] and those who undergo digital cervical examination [
         <a href="#rid40">
          40
         </a>
         ]. The observation that the incidence of chorioamnionitis falls with prolonged latency implies that intrauterine infection may play a smaller role in precipitating delivery in the longer latency pregnancies than in pregnancies that deliver shortly after membrane rupture. This observation has been corroborated by a report that noted that the frequency of inflammatory pathology observed on neonatal head ultrasounds was lower after a longer latency than after a shorter latency [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         Chorioamnionitis can also lead to maternal sepsis [
         <a href="#rid41">
          41
         </a>
         ], but this is unusual with appropriate intervention (eg, antibiotic therapy and delivery). Maternal sepsis complicates approximately 5 percent (5/104) of pregnancies with PROM between 20 and 24 weeks [
         <a href="#rid31">
          31
         </a>
         ] and 1.2 percent (2/174) of pregnancies with PROM between 14 and 23 weeks [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Abruption
         </span>
         <span class="headingEndMark">
          —
         </span>
         Abruption is more common in pregnancies with PROM before or at the limit of viability than in the general obstetric population, 2 to 44 percent versus 0.4 to 1.3 percent [
         <a href="#rid17">
          17
         </a>
         ]. Among pregnancies with PROM before or at the limit of viability, the risk of abruption correlates inversely with gestational age at rupture [
         <a href="#rid24">
          24,42
         </a>
         ]. As an example, the incidence of abruption was 40 to 50 percent in PROM prior to 20 weeks in two studies [
         <a href="#rid24">
          24,42
         </a>
         ] and 17 percent in a study of PROM between 20 and 24 weeks in third study [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6826.html" rel="external">
          "Acute placental abruption: Pathophysiology, clinical features, diagnosis, and consequences"
         </a>
         .)
        </p>
        <p>
         Chronic abruption is likely one cause of PROM before or at the limit of viability. There is abundant evidence that thrombin enhances fetal membrane and/or decidual cytokine and/or protease production, which could exacerbate membrane damage [
         <a href="#rid43">
          43-47
         </a>
         ]. Abruption-associated thrombin also appears to decrease expression of decidual cell progesterone receptor, which promotes preterm birth [
         <a href="#rid48">
          48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6785.html" rel="external">
          "Spontaneous preterm birth: Pathogenesis", section on '#3 Decidual hemorrhage'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Cord prolapse
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is a small risk of cord prolapse during expectant management of patients with PROM before or at the limit of viability, and this risk should be considered when monitoring these pregnancies as they reach and go beyond a viable gestational age, given the potential for an adverse outcome. A review of nine studies including 731 patients with PROM before or at the limit of viability reported a 1.9 percent incidence of cord prolapse [
         <a href="#rid49">
          49
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4461.html" rel="external">
          "Umbilical cord prolapse"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Fetal death
         </span>
         <span class="headingEndMark">
          —
         </span>
         The reported incidence of fetal death after PROM before or at the limit of viability varies depending on the inclusion of pregnancy terminations versus spontaneous fetal loss. In one series of 93 pregnancies with PROM at 15 to 24 weeks, 27 percent underwent a pregnancy termination; of the remaining pregnancies, fetal demise occurred in 30 percent [
         <a href="#rid33">
          33
         </a>
         ]. In another cohort, 7 and 1 percent of pregnancies were terminated at 22 and 23 weeks, respectively; the risk of stillbirth was 8 percent at both 22 and 23 weeks but fell sharply to 3 percent by 25 weeks [
         <a href="#rid28">
          28
         </a>
         ]. The risk of fetal death appears to be inversely related to gestational age at PROM [
         <a href="#rid22">
          22,26,28
         </a>
         ]. In one study, the prevalence of fetal death prior to 20 weeks, prior to 24 weeks, and after 25 weeks was 33, 20, and 0 percent, respectively.
        </p>
        <p>
         Fetal death in PROM before or at the limit of viability is typically caused by abruption, cord prolapse, or infection [
         <a href="#rid22">
          22,26
         </a>
         ]. Use of emergency cesarean birth to avoid fetal death when these complications occur is less prevalent at the limit of viability than later in gestation, given the poor pediatric prognosis.
        </p>
        <p>
         Residual amniotic fluid seems to be protective against fetal death. All deaths in one series occurred in pregnancies in which the largest fluid pocket was &lt;2 cm in greatest diameter [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         In twin pregnancies with PROM of one sac at &lt;26 weeks, a retrospective study observed a significantly higher rate of fetal death in the twin with ruptured membranes (6/23 [26.1 percent] versus 1/23 [4.4 percent]) [
         <a href="#rid51">
          51
         </a>
         ]. Other outcomes were similar for both twins.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Cesarean birth
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cesarean birth rate is increased in pregnancies with PROM before or at the limit of viability, due to an increased prevalence of fetal heart rate abnormalities and fetal malpresentation. A classical hysterotomy will be required since the lower uterine segment is highly unlikely to be sufficiently developed remote from term [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Retained placenta
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevalence of retained placenta necessitating manual removal is increased (9 to 18 percent) with PROM before or at the limit of viability, especially if membrane rupture occurs prior to 20 weeks of gestation [
         <a href="#rid12">
          12,19,22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15333.html" rel="external">
          "Retained placenta after vaginal birth"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Postpartum endometritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postpartum endometritis occurs in up to 40 percent of patients with PROM before or at the limit of viability; the author calculated a weighted cumulative average risk of approximately 13 percent from review of the literature. Postpartum maternal sepsis is less common (0 to 3 percent) [
         <a href="#rid12">
          12,13,16-26,39
         </a>
         ]. The risk of maternal infection appears to be inversely proportional to the latency period [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5488.html" rel="external">
          "Postpartum endometritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H546700680">
         <span class="h1">
          PEDIATRIC OUTCOMES
         </span>
        </p>
        <p class="headingAnchor" id="H546700953">
         <span class="h2">
          Morbidity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Short- and long-term morbidity is common and primarily related to gestational age at birth [
         <a href="#rid1">
          1,2,7,52
         </a>
         ]. Although the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network provides an
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.nichd.nih.gov%2Fabout%2Forg%2Fder%2Fbranches%2Fppb%2Fprograms%2Fepbo%2Fpages%2Fepbo_case.aspx&amp;token=%2BHswNS5aLBdzKU4bwYCGY9aIU2Ev%2FejrA%2BY5mJn%2Bun4lL80yWV30tYfTbLowq6CyH1SQx1%2BFWEK3JNtOreqkTZWgKGLBjRKPyTxRT1jX6JQ%3D&amp;TOPIC_ID=6741" target="_blank">
          online calculator
         </a>
         to estimate the risk of neurodevelopmental impairment of extremely preterm birth based on gestational age at birth, birth weight, sex, singleton birth, and exposure to antenatal corticosteroids within seven days, it does not account for the specific effects of pregnancy complications such as PROM before or at the limit of viability, which increases the risks of pulmonary hypoplasia and infection. Infection-related morbidities include sepsis, meningitis, and pneumonia.
        </p>
        <p>
         The prognosis for intact survival after PROM before or at the limit of viability is only fair. In one study, early PROM was associated with greater composite severe childhood morbidity at age two years than later PROM, even after controlling for delivery gestational age and other confounders [
         <a href="#rid2">
          2
         </a>
         ]. In three studies of pregnancies complicated by PROM before or at the limit of viability, two reported that approximately 50 percent of offspring had no severe morbidity at two years of corrected age [
         <a href="#rid31">
          31,53
         </a>
         ] and one reported 70 percent had normal neurodevelopment but more than half had respiratory problems at two and/or five years of age [
         <a href="#rid54">
          54
         </a>
         ]. However, in another study, 90 and 64 percent of 22- and 23-week PROM survivors were diagnosed with some form of cerebral palsy [
         <a href="#rid28">
          28
         </a>
         ]. Multiple gestation does not appear to affect outcome [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
         Prolonged latency alone is not associated with an increasing frequency of abnormal neonatal cranial ultrasound examination, and there is no evidence that planned early delivery will prevent adverse sequelae [
         <a href="#rid37">
          37,55
         </a>
         ].
        </p>
        <p>
         Specific complications of prematurity are reviewed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4965.html" rel="external">
          "Overview of short-term complications in preterm infants"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5033.html" rel="external">
          "Overview of the long-term complications of preterm birth"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13511.html" rel="external">
          "Periviable birth (limit of viability)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H546701053">
         <span class="h2">
          Neonatal death
         </span>
         <span class="headingEndMark">
          —
         </span>
         The neonatal mortality rate after PROM before or at the limit of viability is high, primarily due to the short latency period, which results in an early gestational age at delivery [
         <a href="#rid12">
          12,13,16-26,28,29,31,38,39,56-61
         </a>
         ]. However, gestational age-specific mortality is similar to that for controls without PROM [
         <a href="#rid25">
          25,39
         </a>
         ]. Neonatal death after discharge remains low, between 1 to 2 percent [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Since mean latency in PROM before or at the limit of viability is 11 days, PROM occurring at 23 to 24 weeks of gestation is more likely to be associated with neonatal survival than PROM at or before 22 weeks [
         <a href="#rid14">
          14,17,20,22,26,62
         </a>
         ]. Neonatal survival improves significantly after 25 weeks of gestation [
         <a href="#rid21">
          21,23,28,39
         </a>
         ]. In a review of three studies of PROM at 14 or 16 to 24 weeks, neonatal survival after conservatively managed PROM at &lt;22 weeks was significantly lower than PROM at 22 to 24 weeks (8/57 [14.4 percent] versus 30/52 [57.7] percent) [
         <a href="#rid1">
          1
         </a>
         ]. A study of pregnancies with PROM at 20 to 23 weeks and latency of at least seven days reported neonatal survival in 90 percent (52/58) [
         <a href="#rid63">
          63
         </a>
         ]. However, these data likely overstate survival because of exclusion of patients who delivered soon after PROM or elected pregnancy termination for persistent fluid leakage, oligohydramnios, abnormal ultrasound findings, or other issues associated with a poor prognosis. A study of PROM between 20 and 24 weeks that did not exclude patients with latency less than seven days reported neonatal survival in 49 percent (51/104) [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         The risk of neonatal mortality is also correlated with residual amniotic fluid volume [
         <a href="#rid17">
          17,26,57,60
         </a>
         ]. In one study, for neonates delivering at the same gestational age, neonatal survival was 98 percent when the largest amniotic fluid pocket was ≥2 cm but only 31 percent when &lt;2 cm. [
         <a href="#rid17">
          17
         </a>
         ]. The survival rate for pregnancies associated with iatrogenic PROM before or at the limit of viability is severalfold higher than that for spontaneous PROM before or at the limit of viability [
         <a href="#rid64">
          64
         </a>
         ]. This may be related to a lower rate of infection, higher residual amniotic fluid volume, higher rate of resealing, or other factors.
        </p>
        <p class="headingAnchor" id="H546703250">
         <span class="h2">
          Pulmonary hypoplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Newborns with pulmonary hypoplasia have small lungs with relatively normal compliance, high pulmonary vascular resistance, reduced pulmonary blood flow, and some degree of systolic and diastolic cardiac dysfunction [
         <a href="#rid65">
          65
         </a>
         ]. The prevalence of pulmonary hypoplasia in neonates of pregnancies complicated by PROM before or at the limit of viability is approximately 30 percent [
         <a href="#rid33">
          33
         </a>
         ]. The mortality rate for these neonates is 70 to 90 percent [
         <a href="#rid24">
          24,26,38,50,56
         </a>
         ].
        </p>
        <p>
         The gestational age at the time of membrane rupture is the critical factor in the risk of subsequent neonatal pulmonary hypoplasia [
         <a href="#rid18">
          18,26,27,29,38,66
         </a>
         ]. In one study of pregnancies less than 29 weeks of gestation, as the gestational age at occurrence of PROM increased, the odds of pulmonary hypoplasia decreased by 46 percent per week [
         <a href="#rid56">
          56
         </a>
         ]. Several series have reported a low incidence (less than 1.4 percent) of pulmonary hypoplasia when PROM occurred after 26 weeks of gestation [
         <a href="#rid24">
          24,27,29,38,56
         </a>
         ]. This gestational age corresponds to the end of the canalicular stage of lung development, after which the developing acinar structure becomes less sensitive to external perturbations  (
         <a class="graphic graphic_table graphicRef72141" href="/z/d/graphic/72141.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
         The degree of oligohydramnios is an additional risk factor for pulmonary hypoplasia; lower volumes of residual fluid confer the highest risk [
         <a href="#rid26">
          26,50,57
         </a>
         ]. In one study, the incidence of pulmonary hypoplasia with severe, moderate, and no to mild oligohydramnios was 43, 19, and 7 percent, respectively [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         It is less clear whether there is an association between the length of the latency period and risk of pulmonary hypoplasia. One study found the median latency period was longer in cases of pulmonary hypoplasia than in those without (31 and 7 days, respectively) [
         <a href="#rid25">
          25
         </a>
         ]. However, this finding may represent a relationship between earlier gestational age at rupture and longer latency rather than an independent effect of the latency period itself. Others have not confirmed this association [
         <a href="#rid50">
          50,56
         </a>
         ].
        </p>
        <p>
         Lethal pulmonary hypoplasia is difficult to diagnosis antepartum. A variety of sonographic methods have been evaluated (eg, thoracic circumference, thoracic:abdominal ratio), but no method has proven sufficiently reliable for clinical decision-making [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H546704473">
         <span class="h2">
          Musculoskeletal development
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most limb development is in the embryonic period [
         <a href="#rid69">
          69
         </a>
         ]. The appendicular skeleton is premolded in cartilage by the end of this period and ossification centers first appear between 12 and 14 weeks postmenstrual age. The majority of limb growth occurs in the second and third trimesters. Asymmetric intrauterine pressure and restriction in fetal movement associated with PROM before or at the limit of viability can lead to deformities of variable severity in previously normally formed extremities [
         <a href="#rid70">
          70
         </a>
         ]. An increased likelihood of skeletal deformities has been observed among infants diagnosed with pulmonary hypoplasia [
         <a href="#rid29">
          29,38,56
         </a>
         ], suggesting that the two disorders have a common etiology. (See
         <a class="medical medical_review" href="/z/d/html/2940.html" rel="external">
          "Congenital anomalies: Approach to evaluation"
         </a>
         .)
        </p>
        <p>
         The frequency of skeletal deformities varies widely among studies; the mean incidence is 7 percent [
         <a href="#rid12">
          12,13,16-26,29,38,39,56,57
         </a>
         ]. In contrast to pulmonary hypoplasia, the gestational age at previable PROM is not a significant determinant of the risk of skeletal abnormalities [
         <a href="#rid29">
          29,38,56,57
         </a>
         ]. This difference is likely due to the progressive and continuous development of the axial skeleton in contrast with the phases of biochemical maturation observed in the lung. Thus, a severe insult of prolonged duration, regardless of gestational age, should be more predictive of skeletal abnormalities than pulmonary abnormalities.
        </p>
        <p>
         This hypothesis is supported by several series that observed that the duration of latency and the severity of oligohydramnios independently increase the risk of skeletal abnormalities and act synergistically to raise the risk beyond the effect of either variable alone [
         <a href="#rid29">
          29,38,56
         </a>
         ]. As an example, one study reported the risk of skeletal abnormality was twofold higher in pregnancies with PROM before or at the limit of viability complicated by severe oligohydramnios (defined as largest pocket less than 1 cm) than in matched pregnancies with normal or mildly reduced fluid (26 versus 54 percent); the risk was highest after 14 days of latency [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         Limb deformations related to PROM before or at the limit of viability generally do not require surgical correction as they gradually resolve with postnatal growth and development [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          APPROACH TO PREGNANCY MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of PROM before or at the limit of viability differs from rupture of membranes later in gestation because the risks of expectant management versus delivery are quite different remote from term. The limit of viability is defined as the stage of fetal maturity that ensures a reasonable chance of survival. Determining the limit of viability is desirable so that costly and painful interventions can be avoided if the neonate does not have a chance of survival. However, deciding upon a threshold of viability is challenging because it remains uncertain which extremely preterm newborn has a reasonable chance of survival. Institutional variability in survival at the limit of viability is due, at least in part, to varying levels of aggressive management.
        </p>
        <p class="headingAnchor" id="H546709479">
         <span class="h2">
          Previable pregnancy at membrane rupture
         </span>
         <span class="headingEndMark">
          —
         </span>
         In previable pregnancies, the risks and benefits of expectant management versus pregnancy termination are discussed. Shared decision-making is paramount with a high degree of sensitivity to the patient's values and circumstances [
         <a href="#rid71">
          71,72
         </a>
         ]. Most patients at this gestational age who are stable and choose to continue their pregnancies are not admitted to the hospital and not given antenatal corticosteroids, or tocolytics, but a rectovaginal group B
         <em>
          Streptococcus
         </em>
         (GBS) culture is obtained. Antibiotic prophylaxis may be considered as early as 20 weeks of gestation [
         <a href="#rid73">
          73
         </a>
         ], although the author waits until 23 weeks (see
         <a class="local">
          'Pregnancies at the limit of viability at membrane rupture'
         </a>
         below) Treatment for a positive GBS culture is initiated when the patient has reached a viable gestational age and is in labor with a high likelihood of delivery. (See
         <a class="medical medical_review" href="/z/d/html/120959.html" rel="external">
          "Preterm prelabor rupture of membranes: Management and outcome", section on 'Administer prophylactic antibiotic therapy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/438.html" rel="external">
          "Prevention of early-onset group B streptococcal disease in neonates", section on 'Preterm prelabor rupture of membranes'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H546709485">
         <span class="h2">
          Pregnancies at the limit of viability at membrane rupture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of pregnancies at the limit of viability varies depending on patient-specific factors and preferences [
         <a href="#rid71">
          71
         </a>
         ]. These patients are admitted to the hospital for usual management of PROM at the gestational age when they would want aggressive neonatal intervention. A common practice among neonatologists is to not offer or provide neonatal resuscitation to neonates &lt;22+0 weeks of gestation due to the low chance of intact survival. Likewise, between 22+0 and 23 or 24 weeks, it is also a common practice among neonatologists to offer neonatal resuscitation to parents if there is at least a small chance of survival based on available information and provide or withhold resuscitation based on the preference of informed parents. (See
         <a class="medical medical_review" href="/z/d/html/13511.html" rel="external">
          "Periviable birth (limit of viability)"
         </a>
         .)
        </p>
        <p>
         All patients are therefore offered admission in the 23
         <sup>
          rd
         </sup>
         week, and the author offers a course of glucocorticoid therapy in the mid-22
         <sup>
          nd
         </sup>
         week. Administration of antenatal corticosteroids in the 22
         <sup>
          nd
         </sup>
         week is reasonable if delivery in the 23
         <sup>
          rd
         </sup>
         week is anticipated and the patient desires aggressive neonatal intervention after thorough consultation with maternal-fetal medicine and neonatology specialists. The author feels strongly that the decision to administer prophylactic glucocorticoids at this margin of viability should be independent of the intention to provide emergency cesarean birth. By the 23
         <sup>
          rd
         </sup>
         week of gestation, he routinely provides emergency cesarean birth intervention for standard obstetric indications. Parents should be informed that antenatal glucocorticoids may provide a survival benefit while increasing the risk of survival with severe impairment. Also, if the pregnancy is not delivered, then a single repeat course of antenatal corticosteroids may be needed later in gestation. (See
         <a class="medical medical_review" href="/z/d/html/6796.html" rel="external">
          "Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery", section on 'Candidates for a first ACS course by gestational age'
         </a>
         .)
        </p>
        <p>
         Antibiotic prophylaxis to prolong latency is administered at admission according to the same protocol used in patients who present with preterm PROM at later gestational ages. The author initiates daily fetal testing after viability, as well. While many of the risks that preterm PROM poses to fetal well-being cannot be predicted by testing, abnormal test results can be an early indicator of impending clinical chorioamnionitis, and the testing is interpreted in this light. A case series of 213 pregnancies with PROM &lt;23 weeks suggests that antibiotic therapy was associated with longer latency and improved neonatal outcomes. The authors acknowledged, however, that this was not a randomized trial and that the improved survival may have been a consequence of increased antibiotic use at later, rather than earlier, gestational ages [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">
          Magnesium sulfate
         </a>
         for neuroprotection is administered after viability when delivery appears to be imminent. Similarly, prophylaxis for GBS should not be administered unless a delivery is anticipated at or beyond viability. (See
         <a class="medical medical_review" href="/z/d/html/120959.html" rel="external">
          "Preterm prelabor rupture of membranes: Management and outcome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H546709583">
         <span class="h2">
          Pregnancies at a viable gestational age
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of pregnancies with PROM at a gestational age when neonatal resuscitation is routinely provided is similar to that for preterm PROM later in gestation. (See
         <a class="medical medical_review" href="/z/d/html/6754.html" rel="external">
          "Preterm prelabor rupture of membranes: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H546709755">
         <span class="h1">
          MANAGEMENT OF PREGNANCY COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3117169265">
         <span class="h2">
          Life-threatening complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infection and abruption are potentially life-threatening maternal complications. The French National Confidential Enquiry into Maternal Deaths identified seven deaths between 2001 and 2015 associated with previable PROM: six deaths were attributed to sepsis after genital infection by Gram-negative bacilli and one to postpartum hemorrhage due to placenta accreta [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
         When there is an expectation of neonatal survival, the route of delivery is determined by the obstetric indication. (See
         <a class="medical medical_review" href="/z/d/html/13511.html" rel="external">
          "Periviable birth (limit of viability)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1081419847">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical chorioamnionitis is an indication for immediate delivery because expectant management increases the risks for maternal morbidity and death, fetal death, and neonatal morbidity and death. Approximately 10 percent of patients with clinical chorioamnionitis managed expectantly will be diagnosed with sepsis, which can evolve rapidly despite administration of antibiotics [
         <a href="#rid76">
          76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/130878.html" rel="external">
          "Septic abortion: Clinical presentation and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1657.html" rel="external">
          "Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H107949453">
         <span class="h3">
          Abruption
         </span>
         <span class="headingEndMark">
          —
         </span>
         Abruption is an indication for immediate delivery when rapid control of bleeding is required because of maternal hemodynamic instability or significant coagulopathy. Expectant management is not appropriate. Patients with suspected placental abruption should be managed as inpatients in a facility with sufficient resources to provide immediate maternal resuscitation in the event of severe abruption. (See
         <a class="medical medical_review" href="/z/d/html/6826.html" rel="external">
          "Acute placental abruption: Pathophysiology, clinical features, diagnosis, and consequences"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6803.html" rel="external">
          "Acute placental abruption: Management and long-term prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Coexistent cerclage
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is unclear whether foreign material in the cervix after cerclage placement increases the risk of maternal or neonatal sepsis in the setting of PROM before or at the limit of viability; the most appropriate management in this clinical setting remains controversial. The author leaves the cerclage in situ in the absence of signs of labor or intrauterine infection. This topic is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6737.html" rel="external">
          "Transvaginal cervical cerclage", section on 'Removal of cerclage after PPROM'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H598582542">
         <span class="h2">
          Delayed interval delivery of multiple gestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple gestations with PROM before or at the limit of viability are managed in the same way as singletons. While some clinicians believe delayed-interval delivery is an option for pregnancies at an early gestational age (&lt;24 weeks) in which only the first (presenting) fetus spontaneously delivers, this has not been the author's policy given the heightened risks of maternal intrauterine infection. The safety and efficacy of delayed-interval delivery is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6771.html" rel="external">
          "Multifetal gestation: Approach to delayed-interval delivery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1104609024">
         <span class="h1">
          UNPROVEN INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H285784638">
         <span class="h2">
          Prophylactic antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         The utility of latency antibiotics in the periviable period remains controversial and unclear. The author never administers prophylactic antibiotics prior to 20+0 weeks of gestation for the indication of prolonging latency. He generally does not administer antibiotic prophylaxis prior to 22+0 weeks as the potential addition of one week at this gestational age, on average, rarely has benefit in the overall context of fetal development. However, use of broad spectrum antibiotic prophylaxis is a common practice [
         <a href="#rid1">
          1,77
         </a>
         ] based on data from observational studies [
         <a href="#rid39">
          39,60,78
         </a>
         ] and extrapolation of results from randomized trials at later gestational ages.
        </p>
        <p>
         Data from randomized trials show that antibiotic prophylaxis after membrane rupture before 34 weeks and before 37 weeks increases latency by approximately one week; however, no similar trials have been performed among patients with previable PROM to support either the efficacy or safety of this therapy at previable gestational ages.
        </p>
        <p class="headingAnchor" id="H2530438810">
         <span class="h2">
          Amnioinfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         The author does not perform amnioinfusion to prevent complications from oligohydramnios. The use of serial amnioinfusions is controversial, with only sparse data and no convincing evidence of benefit available in PROM before or at the limit of viability [
         <a href="#rid79">
          79-81
         </a>
         ]. Some groups have, however, observed an increased latency period with amnioinfusion. One such study reported median latency with versus without amnioinfusion was 13 and 4 days, respectively [
         <a href="#rid82">
          82
         </a>
         ] and the other reported median latency of 5.5 and 3 weeks, respectively, as well as improved neonatal morbidity [
         <a href="#rid83">
          83
         </a>
         ]. More studies of the safety and efficacy of the procedure in this setting are needed before prophylactic amnioinfusion can be recommended. (See
         <a class="medical medical_review" href="/z/d/html/120959.html" rel="external">
          "Preterm prelabor rupture of membranes: Management and outcome", section on 'Amnioinfusion'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3649150349">
         <span class="h2">
          Repair of leaks
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of tissue sealants (eg, fibrin glue, gelatin sponge, amniopatch) have shown some success in case reports [
         <a href="#rid15">
          15
         </a>
         ]. Neither the safety nor the efficacy of these sealants has been established [
         <a href="#rid84">
          84
         </a>
         ]. Furthermore, thrombin may trigger fetal membrane matrix and/or decidual metalloproteinase and inflammatory cytokine production and decrease decidual cell progesterone receptor expression, which can increase myometrial contractions and promote further membrane damage and premature delivery [
         <a href="#rid43">
          43,45,47,85
         </a>
         ].
        </p>
        <p>
         Intra-amniotic injection of platelets and cryoprecipitate (ie, amniopatch) has also been used to treat iatrogenic rupture [
         <a href="#rid86">
          86-89
         </a>
         ]. Although sometimes successful, the procedure has been associated with unexpected fetal death and should be considered investigational.
        </p>
        <p>
         An evaluation of resealing technologies and protocols by the Cochrane group concluded that there is insufficient evidence to recommend any resealing protocol in contemporary clinical practice [
         <a href="#rid84">
          84
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          RECURRENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with PROM before or at the limit of viability are at high risk of recurrence in subsequent pregnancies. An early prior spontaneous preterm delivery appears to be more predictive of recurrence than late preterm delivery, and highly associated with a subsequent early spontaneous preterm delivery [
         <a href="#rid90">
          90
         </a>
         ]. In a retrospective cohort study of 108 patients with a history of one or more singleton pregnancies complicated by PROM &lt;24 weeks of gestation, 46 percent (50/108) delivered preterm in the pregnancy immediately after the index delivery and 17 percent (18/108) delivered before 24 weeks [
         <a href="#rid91">
          91
         </a>
         ]. In another study of 99 patients with PROM &lt;27 weeks, recurrent preterm delivery occurred in 35 percent and 9 percent had recurrent PROM &lt;27 weeks [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
         Given the increased risk of recurrence, modifiable risk factors such as cigarette smoking and short interpregnancy interval should be addressed. In consultation with their providers, enhanced surveillance in a future pregnancy, potentially in collaboration with a clinic specializing in preterm birth prevention, might be useful.
        </p>
        <p>
         Patients with a history of cervical insufficiency in a prior pregnancy are probably at increased risk of previable PROM in a subsequent pregnancy, given the common etiology of both entities. (See
         <a class="medical medical_review" href="/z/d/html/6774.html" rel="external">
          "Cervical insufficiency"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1902475048">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117941.html" rel="external">
          "Society guideline links: Prelabor rupture of membranes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13138769">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/82972.html" rel="external">
          "Patient education: Preterm prelabor rupture of membranes (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology and etiology
         </strong>
         – Prelabor rupture of membranes (PROM) before or at the limit of viability complicates up to 0.7 percent of pregnancies. It may be spontaneous or a complication of an invasive obstetric procedure. PROM before or at the limit of viability after amniocentesis has a much better prognosis than spontaneous PROM before or at the limit of viability because membranes often reseal after amniocentesis. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Causes and risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mean latency
         </strong>
         – The time interval between membrane rupture and delivery is a critical factor in determining outcome. The mean latency from gestational age at PROM to delivery is approximately 17 days and the median latency is approximately one week, since the majority of pregnancies deliver soon after rupture of membranes. (See
         <a class="local">
          'Latency/preterm birth'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications
         </strong>
         – Pregnancy complications associated with PROM before or at the limit of viability include increased risks of infection (chorioamnionitis, endometritis), abruptio placentae, cord prolapse, fetal death, preterm birth, and need for cesarean delivery. (See
         <a class="local">
          'Pregnancy complications and outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Resealing
         </strong>
         – Cessation of amniotic fluid leakage with reaccumulation of amniotic fluid confers a prognosis comparable to that of pregnancies without previable PROM. (See
         <a class="local">
          'Resealing and reaccumulation of fluid'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The safety and efficacy of tissue sealants for repair of PROM have not been established. (See
         <a class="local">
          'Repair of leaks'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We recommend antenatal glucocorticoids at ≥23+0 weeks of gestation (
         <a class="grade" href="https:///uptodate/show/grade_1" rel="external">
          Grade 1A
         </a>
         ). A course of glucocorticoids in the 22
         <sup>
          nd
         </sup>
         week is reasonable if delivery in the 23
         <sup>
          rd
         </sup>
         week is anticipated. (See
         <a class="medical medical_review" href="/z/d/html/6796.html" rel="external">
          "Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infection and abruption are potentially life-threatening maternal complications that require delivery. When there is an expectation of neonatal survival, the route of delivery is determined by the obstetric indication. (See
         <a class="local">
          'Life-threatening complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Management of PROM before or at the limit of viability (the stage of fetal maturity that ensures a reasonable chance of survival) differs from PROM later in pregnancy.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Previable pregnancy at membrane rupture
         </strong>
         – The risks and benefits of expectant management versus pregnancy termination are discussed. Most women at this gestational age who are stable and choose to continue their pregnancies are not admitted to the hospital and not given antenatal corticosteroids, tocolytics, or prophylactic antibiotics, but we obtain a rectovaginal group B streptococcus culture. They are admitted to the hospital for usual management of PROM at the gestational age when they would want aggressive neonatal intervention. (See
         <a class="local">
          'Previable pregnancy at membrane rupture'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Pregnancies at the limit of viability at membrane rupture
         </strong>
         – Management of these pregnancies depends on patient-specific factors and preferences. These women are admitted to the hospital for usual management of PROM at the gestational age when they would want aggressive neonatal intervention. Between 22 and 23 or 24 weeks, a common practice among neonatologists is to offer neonatal resuscitation to parents if there is at least a small chance of survival based on available information and provide or withhold resuscitation based on the preference of informed parents.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         We routinely administer a full course of antenatal corticosteroids to pregnancies at ≥23 weeks of gestation and offer corticosteroid therapy in the mid-22
         <sup>
          nd
         </sup>
         week. By the 23
         <sup>
          rd
         </sup>
         week of gestation, we routinely provide emergency cesarean delivery intervention for standard obstetric indications.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         Parents should be informed that antenatal corticosteroids may provide a survival benefit while increasing the risk of survival with severe impairment. Also, if the pregnancy is not delivered, then a single repeat course of antenatal corticosteroids may be needed later in gestation. (See
         <a class="local">
          'Pregnancies at the limit of viability at membrane rupture'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Pregnancies at a viable gestational age
         </strong>
         – Our management of pregnancies with preterm PROM at a gestational age when neonatal resuscitation is routinely provided is similar to that for preterm PROM later in gestation. (See
         <a class="medical medical_review" href="/z/d/html/6754.html" rel="external">
          "Preterm prelabor rupture of membranes: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neonatal outcome
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neonatal survival is primarily related to gestational age at delivery, and is comparable to that in preterm deliveries matched for gestational age without PROM before or at the limit of viability. For these very early gestations, gains in fetal maturity with expectant management dramatically improve survival. (See
         <a class="local">
          'Neonatal death'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The neonate is at risk for morbidity/mortality related to preterm birth, infection, pulmonary hypoplasia, and musculoskeletal deformation. (See
         <a class="local">
          'Pediatric outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Waters TP, Mercer BM. The management of preterm premature rupture of the membranes near the limit of fetal viability. Am J Obstet Gynecol 2009; 201:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manuck TA, Varner MW. Neonatal and early childhood outcomes following early vs later preterm premature rupture of membranes. Am J Obstet Gynecol 2014; 211:308.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linehan LA, Walsh J, Morris A, et al. Neonatal and maternal outcomes following midtrimester preterm premature rupture of the membranes: a retrospective cohort study. BMC Pregnancy Childbirth 2016; 16:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McElrath TF, Hecht JL, Dammann O, et al. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol 2008; 168:980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold RB, Goyert GL, Schwartz DB, et al. Conservative management of second-trimester post-amniocentesis fluid leakage. Obstet Gynecol 1989; 74:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borgida AF, Mills AA, Feldman DM, et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol 2000; 183:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acaia B, Crovetto F, Ossola MW, et al. Predictive factors for neonatal survival in women with periviable preterm rupture of the membranes. J Matern Fetal Neonatal Med 2013; 26:1628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gratacós E, Deprest J. Current experience with fetoscopy and the Eurofoetus registry for fetoscopic procedures. Eur J Obstet Gynecol Reprod Biol 2000; 92:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beck V, Lewi P, Gucciardo L, Devlieger R. Preterm prelabor rupture of membranes and fetal survival after minimally invasive fetal surgery: a systematic review of the literature. Fetal Diagn Ther 2012; 31:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muniz Rodriguez A, Pastor A, Fox NS. The Association between Shirodkar Cerclage and Preterm Premature Rupture of Membranes in Singleton Pregnancies. Am J Perinatol 2021; 38:e347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berghella V, Ciardulli A, Rust OA, et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol 2017; 50:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beydoun SN, Yasin SY. Premature rupture of the membranes before 28 weeks: conservative management. Am J Obstet Gynecol 1986; 155:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortunato SJ, Welt SI, Eggleston MK Jr, Bryant EC. Active expectant management in very early gestations complicated by premature rupture of the fetal membranes. J Reprod Med 1994; 39:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shenker L, Reed KL, Anderson CF, Borjon NA. Significance of oligohydramnios complicating pregnancy. Am J Obstet Gynecol 1991; 164:1597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devlieger R, Millar LK, Bryant-Greenwood G, et al. Fetal membrane healing after spontaneous and iatrogenic membrane rupture: a review of current evidence. Am J Obstet Gynecol 2006; 195:1512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hibbard JU, Hibbard MC, Ismail M, Arendt E. Pregnancy outcome after expectant management of premature rupture of the membranes in the second trimester. J Reprod Med 1993; 38:945.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hadi HA, Hodson CA, Strickland D. Premature rupture of the membranes between 20 and 25 weeks' gestation: role of amniotic fluid volume in perinatal outcome. Am J Obstet Gynecol 1994; 170:1139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moretti M, Sibai BM. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988; 159:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor J, Garite TJ. Premature rupture of membranes before fetal viability. Obstet Gynecol 1984; 64:615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowd J, Permezel M. Pregnancy outcome following preterm premature rupture of the membranes at less than 26 weeks' gestation. Aust N Z J Obstet Gynaecol 1992; 32:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bengtson JM, VanMarter LJ, Barss VA, et al. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation. Obstet Gynecol 1989; 73:921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Major CA, Kitzmiller JL. Perinatal survival with expectant management of midtrimester rupture of membranes. Am J Obstet Gynecol 1990; 163:838.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rib DM, Sherer DM, Woods JR Jr. Maternal and neonatal outcome associated with prolonged premature rupture of membranes below 26 weeks' gestation. Am J Perinatol 1993; 10:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farooqi A, Holmgren PA, Engberg S, Serenius F. Survival and 2-year outcome with expectant management of second-trimester rupture of membranes. Obstet Gynecol 1998; 92:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurkinen-Räty M, Koivisto M, Jouppila P. Perinatal and neonatal outcome and late pulmonary sequelae in infants born after preterm premature rupture of membranes. Obstet Gynecol 1998; 92:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shumway JB, Al-Malt A, Amon E, et al. Impact of oligohydramnios on maternal and perinatal outcomes of spontaneous premature rupture of the membranes at 18-28 weeks. J Matern Fetal Med 1999; 8:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Falk SJ, Campbell LJ, Lee-Parritz A, et al. Expectant management in spontaneous preterm premature rupture of membranes between 14 and 24 weeks' gestation. J Perinatol 2004; 24:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lorthe E, Torchin H, Delorme P, et al. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). Am J Obstet Gynecol 2018; 219:298.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nimrod C, Varela-Gittings F, Machin G, et al. The effect of very prolonged membrane rupture on fetal development. Am J Obstet Gynecol 1984; 148:540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Storness-Bliss C, Metcalfe A, Simrose R, et al. Correlation of residual amniotic fluid and perinatal outcomes in periviable preterm premature rupture of membranes. J Obstet Gynaecol Can 2012; 34:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kibel M, Asztalos E, Barrett J, et al. Outcomes of Pregnancies Complicated by Preterm Premature Rupture of Membranes Between 20 and 24 Weeks of Gestation. Obstet Gynecol 2016; 128:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dotters-Katz SK, Panzer A, Grace MR, et al. Maternal Morbidity After Previable Prelabor Rupture of Membranes. Obstet Gynecol 2017; 129:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiver V, Boos V, Thomas A, et al. Perinatal outcomes after previable preterm premature rupture of membranes before 24 weeks of gestation. J Perinat Med 2018; 46:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997; 89:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hillier SL, Martius J, Krohn M, et al. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319:972.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morales WJ. The effect of chorioamnionitis on the developmental outcome of preterm infants at one year. Obstet Gynecol 1987; 70:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McElrath TF, Allred EN, Leviton A, Development Epidemiology Network Investigators. Prolonged latency after preterm premature rupture of membranes: an evaluation of histologic condition and intracranial ultrasonic abnormality in the neonate born at &lt;28 weeks of gestation. Am J Obstet Gynecol 2003; 189:794.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blott M, Greenough A. Neonatal outcome after prolonged rupture of the membranes starting in the second trimester. Arch Dis Child 1988; 63:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morales WJ, Talley T. Premature rupture of membranes at &lt; 25 weeks: a management dilemma. Am J Obstet Gynecol 1993; 168:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alexander JM, Mercer BM, Miodovnik M, et al. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol 2000; 183:1003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mabie WC, Barton JR, Sibai B. Septic shock in pregnancy. Obstet Gynecol 1997; 90:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmgren PA, Olofsson JI. Preterm premature rupture of membranes and the associated risk for placental abruption. Inverse correlation to gestational length. Acta Obstet Gynecol Scand 1997; 76:743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lockwood CJ, Toti P, Arcuri F, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005; 167:1443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cakmak H, Schatz F, Huang ST, et al. Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery. J Clin Endocrinol Metab 2005; 90:5279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mackenzie AP, Schatz F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004; 191:1996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosen T, Schatz F, Kuczynski E, et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002; 11:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stephenson CD, Lockwood CJ, Ma Y, Guller S. Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes. J Matern Fetal Neonatal Med 2005; 18:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lockwood CJ, Kayisli UA, Stocco C, et al. Abruption-induced preterm delivery is associated with thrombin-mediated functional progesterone withdrawal in decidual cells. Am J Pathol 2012; 181:2138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schucker JL, Mercer BM. Midtrimester premature rupture of the membranes. Semin Perinatol 1996; 20:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vergani P, Ghidini A, Locatelli A, et al. Risk factors for pulmonary hypoplasia in second-trimester premature rupture of membranes. Am J Obstet Gynecol 1994; 170:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong LF, Holmgren CM, Silver RM, et al. Outcomes of expectantly managed pregnancies with multiple gestations and preterm premature rupture of membranes prior to 26 weeks. Am J Obstet Gynecol 2015; 212:215.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sim WH, Ng H, Sheehan P. Maternal and neonatal outcomes following expectant management of preterm prelabor rupture of membranes before viability. J Matern Fetal Neonatal Med 2020; 33:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pristauz G, Bauer M, Maurer-Fellbaum U, et al. Neonatal outcome and two-year follow-up after expectant management of second trimester rupture of membranes. Int J Gynaecol Obstet 2008; 101:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simons NE, de Ruigh AA, van der Windt LI, et al. Maternal, perinatal and childhood outcomes of the PPROMEXIL-III cohort: Pregnancies complicated by previable prelabor rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2021; 265:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Locatelli A, Ghidini A, Paterlini G, et al. Gestational age at preterm premature rupture of membranes: a risk factor for neonatal white matter damage. Am J Obstet Gynecol 2005; 193:947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rotschild A, Ling EW, Puterman ML, Farquharson D. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol 1990; 162:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kilbride HW, Yeast J, Thibeault DW. Defining limits of survival: lethal pulmonary hypoplasia after midtrimester premature rupture of membranes. Am J Obstet Gynecol 1996; 175:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoekstra JH, de Boer R. Very early prolonged premature rupture of membranes and survival. Eur J Pediatr 1990; 149:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dinsmoor MJ, Bachman R, Haney EI, et al. Outcomes after expectant management of extremely preterm premature rupture of the membranes. Am J Obstet Gynecol 2004; 190:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grisaru-Granovsky S, Eitan R, Kaplan M, Samueloff A. Expectant management of midtrimester premature rupture of membranes: a plea for limits. J Perinatol 2003; 23:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manuck TA, Eller AG, Esplin MS, et al. Outcomes of expectantly managed preterm premature rupture of membranes occurring before 24 weeks of gestation. Obstet Gynecol 2009; 114:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McElrath TF, Robinson JN, Ecker JL, et al. Neonatal outcome of infants born at 23 weeks' gestation. Obstet Gynecol 2001; 97:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brumbaugh JE, Colaizy TT, Nuangchamnong N, et al. Neonatal survival after prolonged preterm premature rupture of membranes before 24 weeks of gestation. Obstet Gynecol 2014; 124:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chauleur C, Rochigneux S, Seffert P, et al. Neonatal outcomes and four-year follow-up after spontaneous or iatrogenic preterm prelabor rupture of membranes before 24 weeks. Acta Obstet Gynecol Scand 2009; 88:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Waal K, Kluckow M. Prolonged rupture of membranes and pulmonary hypoplasia in very preterm infants: pathophysiology and guided treatment. J Pediatr 2015; 166:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lauria MR, Gonik B, Romero R. Pulmonary hypoplasia: pathogenesis, diagnosis, and antenatal prediction. Obstet Gynecol 1995; 86:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glasser SW, Korfhagen TR, Wert SE, Whitsett JA. Transgenic models for study of pulmonary development and disease. Am J Physiol 1994; 267:L489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Teeffelen AS, Van Der Heijden J, Oei SG, et al. Accuracy of imaging parameters in the prediction of lethal pulmonary hypoplasia secondary to mid-trimester prelabor rupture of fetal membranes: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2012; 39:495.
          </a>
         </li>
         <li class="breakAll">
          Orthopedic Problems, Chapter 48. In: Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, 5, Mosby Year Book, St Louis 1996.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seeds AE, Hellegers AE. Acid-base determinations in human amniotic fluid throughout pregnancy. Am J Obstet Gynecol 1968; 101:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Ecker JL, Kaimal A, et al. #3: Periviable birth. Am J Obstet Gynecol 2015; 213:604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tucker Edmonds B, McKenzie F, Panoch J, et al. Evaluating shared decision-making in periviable counseling using objective structured clinical examinations. J Perinatol 2019; 39:857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol 2020; 135:e80. Reaffirmed 2023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dotters-Katz SK, Myrick O, Smid M, et al. Use of prophylactic antibiotics in women with previable prelabor rupture of membranes. J Neonatal Perinatal Med 2017; 10:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abrahami Y, Saucedo M, Rigouzzo A, et al. Maternal mortality in women with pre-viable premature rupture of membranes: An analysis from the French confidential enquiry into maternal deaths. Acta Obstet Gynecol Scand 2022; 101:1395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margato MF, Martins GL, Passini Júnior R, Nomura ML. Previable preterm rupture of membranes: gestational and neonatal outcomes. Arch Gynecol Obstet 2012; 285:1529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raju TN, Mercer BM, Burchfield DJ, Joseph GF Jr. Periviable birth: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists. Am J Obstet Gynecol 2014; 210:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiao ZH, André P, Lacaze-Masmonteil T, et al. Outcome of premature infants delivered after prolonged premature rupture of membranes before 25 weeks of gestation. Eur J Obstet Gynecol Reprod Biol 2000; 90:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porat S, Amsalem H, Shah PS, Murphy KE. Transabdominal amnioinfusion for preterm premature rupture of membranes: a systematic review and metaanalysis of randomized and observational studies. Am J Obstet Gynecol 2012; 207:393.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts D, Vause S, Martin W, et al. Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study. Ultrasound Obstet Gynecol 2014; 43:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Kempen LEM, van Teeffelen AS, de Ruigh AA, et al. Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial. Obstet Gynecol 2019; 133:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esaki M, Maseki Y, Tezuka A, Furuhashi M. Continuous amnioinfusion in women with PPROM at periviable gestational ages. J Matern Fetal Neonatal Med 2020; 33:1151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goździewicz T, Rycel-Dziatosz M, Madziar K, et al. Long-Term Amnioinfusion through an Intrauterine Catheter in Preterm Premature Rupture of Membranes before 26 Weeks of Gestation: A Retrospective Multicenter Study. Fetal Diagn Ther 2021; 48:582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crowley AE, Grivell RM, Dodd JM. Sealing procedures for preterm prelabour rupture of membranes. Cochrane Database Syst Rev 2016; 7:CD010218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Sullivan CJ, Allen NM, O'Loughlin AJ, et al. Thrombin and PAR1-activating peptide: effects on human uterine contractility in vitro. Am J Obstet Gynecol 2004; 190:1098.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quintero RA, Morales WJ, Allen M, et al. Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch): preliminary experience. Am J Obstet Gynecol 1999; 181:744.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Contino B, Armellino F, Brokaj L, Patroncini S. Amniopatch, a repairing technique for premature rupture of amniotic membranes in second trimester. Acta Biomed 2004; 75 Suppl 1:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cobo T, Borrell A, Fortuny A, et al. Treatment with amniopatch of premature rupture of membranes after first-trimester chorionic villus sampling. Prenat Diagn 2007; 27:1024.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richter J, Henry A, Ryan G, et al. Amniopatch procedure after previable iatrogenic rupture of the membranes: a two-center review. Prenat Diagn 2013; 33:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mercer BM, Goldenberg RL, Moawad AH, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1999; 181:1216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monson MA, Gibbons KJ, Esplin MS, et al. Pregnancy Outcomes in Women With a History of Previable, Preterm Prelabor Rupture of Membranes. Obstet Gynecol 2016; 128:976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Heyden JL, van Kuijk SM, van der Ham DP, et al. Subsequent Pregnancy after Preterm Prelabor Rupture of Membranes before 27 Weeks' Gestation. AJP Rep 2013; 3:113.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6741 Version 49.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19733274" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The management of preterm premature rupture of the membranes near the limit of fetal viability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24858202" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Neonatal and early childhood outcomes following early vs later preterm premature rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26831896" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Neonatal and maternal outcomes following midtrimester preterm premature rupture of the membranes: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18756014" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2812651" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Conservative management of second-trimester post-amniocentesis fluid leakage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11035342" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23570530" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Predictive factors for neonatal survival in women with periviable preterm rupture of the membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10986450" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Current experience with fetoscopy and the Eurofoetus registry for fetoscopic procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22104520" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Preterm prelabor rupture of membranes and fetal survival after minimally invasive fetal surgery: a systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32446260" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The Association between Shirodkar Cerclage and Preterm Premature Rupture of Membranes in Singleton Pregnancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28295722" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3752169" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Premature rupture of the membranes before 28 weeks: conservative management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8169909" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Active expectant management in very early gestations complicated by premature rupture of the fetal membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2048607" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Significance of oligohydramnios complicating pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16681986" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Fetal membrane healing after spontaneous and iatrogenic membrane rupture: a review of current evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8120852" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Pregnancy outcome after expectant management of premature rupture of the membranes in the second trimester.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8166198" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Premature rupture of the membranes between 20 and 25 weeks' gestation: role of amniotic fluid volume in perinatal outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3407697" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6333658" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Premature rupture of membranes before fetal viability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1520195" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Pregnancy outcome following preterm premature rupture of the membranes at less than 26 weeks' gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2726113" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2403164" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Perinatal survival with expectant management of midtrimester rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8240596" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Maternal and neonatal outcome associated with prolonged premature rupture of membranes below 26 weeks' gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9840545" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Survival and 2-year outcome with expectant management of second-trimester rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9721780" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Perinatal and neonatal outcome and late pulmonary sequelae in infants born after preterm premature rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10052841" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Impact of oligohydramnios on maternal and perinatal outcomes of spontaneous premature rupture of the membranes at 18-28 weeks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15254557" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Expectant management in spontaneous preterm premature rupture of membranes between 14 and 24 weeks' gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29852153" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6702914" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The effect of very prolonged membrane rupture on fetal development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22340064" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Correlation of residual amniotic fluid and perinatal outcomes in periviable preterm premature rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27400016" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Outcomes of Pregnancies Complicated by Preterm Premature Rupture of Membranes Between 20 and 24 Weeks of Gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27926655" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Maternal Morbidity After Previable Prelabor Rupture of Membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28822226" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Perinatal outcomes after previable preterm premature rupture of membranes before 24 weeks of gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9015033" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Placental histology and clinical characteristics of patients with preterm premature rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3262199" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3601280" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The effect of chorioamnionitis on the developmental outcome of preterm infants at one year.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14526316" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Prolonged latency after preterm premature rupture of membranes: an evaluation of histologic condition and intracranial ultrasonic abnormality in the neonate born at&lt;28 weeks of gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3196069" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Neonatal outcome after prolonged rupture of the membranes starting in the second trimester.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8438918" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Premature rupture of membranes at&lt;25 weeks: a management dilemma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11035354" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The impact of digital cervical examination on expectantly managed preterm rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9380315" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Septic shock in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9348251" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Preterm premature rupture of membranes and the associated risk for placental abruption. Inverse correlation to gestational length.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16251427" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15998775" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15592282" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12380602" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16105787" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23058370" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Abruption-induced preterm delivery is associated with thrombin-mediated functional progesterone withdrawal in decidual cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8912993" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Midtrimester premature rupture of the membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8178866" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Risk factors for pulmonary hypoplasia in second-trimester premature rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25218125" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Outcomes of expectantly managed pregnancies with multiple gestations and preterm premature rupture of membranes prior to 26 weeks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29961407" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Maternal and neonatal outcomes following expectant management of preterm prelabor rupture of membranes before viability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18289539" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Neonatal outcome and two-year follow-up after expectant management of second trimester rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34428686" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Maternal, perinatal and childhood outcomes of the PPROMEXIL-III cohort: Pregnancies complicated by previable prelabor rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16157092" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Gestational age at preterm premature rupture of membranes: a risk factor for neonatal white matter damage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2301516" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Neonatal outcome after prolonged preterm rupture of the membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8828433" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Defining limits of survival: lethal pulmonary hypoplasia after midtrimester premature rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2189734" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Very early prolonged premature rupture of membranes and survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14749657" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Outcomes after expectant management of extremely preterm premature rupture of the membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12732862" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Expectant management of midtrimester premature rupture of membranes: a plea for limits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19546755" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Outcomes of expectantly managed preterm premature rupture of membranes occurring before 24 weeks of gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11152906" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Neonatal outcome of infants born at 23 weeks' gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25437729" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Neonatal survival after prolonged preterm premature rupture of membranes before 24 weeks of gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19449217" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Neonatal outcomes and four-year follow-up after spontaneous or iatrogenic preterm prelabor rupture of membranes before 24 weeks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25681201" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Prolonged rupture of membranes and pulmonary hypoplasia in very preterm infants: pathophysiology and guided treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7651663" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Pulmonary hypoplasia: pathogenesis, diagnosis, and antenatal prediction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7977760" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Transgenic models for study of pulmonary development and disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21793083" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Accuracy of imaging parameters in the prediction of lethal pulmonary hypoplasia secondary to mid-trimester prelabor rupture of fetal membranes: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21793083" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Accuracy of imaging parameters in the prediction of lethal pulmonary hypoplasia secondary to mid-trimester prelabor rupture of fetal membranes: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5652958" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Acid-base determinations in human amniotic fluid throughout pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26506448" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : #3: Periviable birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30944399" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Evaluating shared decision-making in periviable counseling using objective structured clinical examinations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32080050" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29286934" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Use of prophylactic antibiotics in women with previable prelabor rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36207816" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Maternal mortality in women with pre-viable premature rupture of membranes: An analysis from the French confidential enquiry into maternal deaths.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22203092" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Previable preterm rupture of membranes: gestational and neonatal outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24725732" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Periviable birth: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10767513" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Outcome of premature infants delivered after prolonged premature rupture of membranes before 25 weeks of gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22999157" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Transabdominal amnioinfusion for preterm premature rupture of membranes: a systematic review and metaanalysis of randomized and observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24265189" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30531572" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30149736" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Continuous amnioinfusion in women with PPROM at periviable gestational ages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34320491" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Long-Term Amnioinfusion through an Intrauterine Catheter in Preterm Premature Rupture of Membranes before 26 Weeks of Gestation: A Retrospective Multicenter Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27384151" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Sealing procedures for preterm prelabour rupture of membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15118649" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Thrombin and PAR1-activating peptide: effects on human uterine contractility in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10486493" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch): preliminary experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15301286" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Amniopatch, a repairing technique for premature rupture of amniotic membranes in second trimester.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17694578" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Treatment with amniopatch of premature rupture of membranes after first-trimester chorionic villus sampling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23512492" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Amniopatch procedure after previable iatrogenic rupture of the membranes: a two-center review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10561648" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27741176" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Pregnancy Outcomes in Women With a History of Previable, Preterm Prelabor Rupture of Membranes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24147248" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Subsequent Pregnancy after Preterm Prelabor Rupture of Membranes before 27 Weeks' Gestation.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
